glp-1 incretin effect receptors aren't limited to the pancreas. They're expressed across the CNS, heart, kidney, and GI tract, which is why the clinical benefits of GLP-1 RAs extend well beyond glucose and weight Wiley Focus

Contrariwise, the same cells cultured in 3D conditions showed no morphological alterations compared to the control

GLP-1 agonists reduce bodyweight through increased satiety signaling in the hypothalamus and delayed gastric emptying, lowering daily caloric intake by 200500 kcal

Alpha-lipoic acid as a dietary supplement: Molecular mechanisms and therapeutic potential

DURATION-5 highlighted higher rates of nausea (and subsequent vomiting) with use of exenatide twice daily compared with the once-weekly formulation, with two patients in the twice daily arm reporting severe nausea, compared to none in the once weekly arm [Blevins et al